WO2008131746A3 - Mittel zur präventiven antiinfektiven behandlung eines patienten - Google Patents

Mittel zur präventiven antiinfektiven behandlung eines patienten Download PDF

Info

Publication number
WO2008131746A3
WO2008131746A3 PCT/DE2008/000719 DE2008000719W WO2008131746A3 WO 2008131746 A3 WO2008131746 A3 WO 2008131746A3 DE 2008000719 W DE2008000719 W DE 2008000719W WO 2008131746 A3 WO2008131746 A3 WO 2008131746A3
Authority
WO
WIPO (PCT)
Prior art keywords
patient
preventative anti
infective treatment
preventative
infective
Prior art date
Application number
PCT/DE2008/000719
Other languages
English (en)
French (fr)
Other versions
WO2008131746A2 (de
Inventor
Olaf Schulte-Herbrueggen
Christian Meisel
Andreas Meisel
David Quarcoo
Thomas Brzoska
Original Assignee
Olaf Schulte-Herbrueggen
Christian Meisel
Andreas Meisel
David Quarcoo
Thomas Brzoska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Olaf Schulte-Herbrueggen, Christian Meisel, Andreas Meisel, David Quarcoo, Thomas Brzoska filed Critical Olaf Schulte-Herbrueggen
Publication of WO2008131746A2 publication Critical patent/WO2008131746A2/de
Publication of WO2008131746A3 publication Critical patent/WO2008131746A3/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Die Erfindung betrifft die Verwendung eines Antagonisten des Melanocortin-1 -Rezeptors gemäß SEQ. ID. NO. 1 und/oder eines Antagonisten des Melanocortin-4-Rezeptors gemäß SEQ. ID. NO. 4 zur Herstellung einer pharmazeutischen Zusammensetzung zur präventiven antiinfektiven Therapie.
PCT/DE2008/000719 2007-04-26 2008-04-28 Mittel zur präventiven antiinfektiven behandlung eines patienten WO2008131746A2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102007020152.6 2007-04-26
DE102007020152A DE102007020152A1 (de) 2007-04-26 2007-04-26 Mittel zur antiinfektiven Behandlung eines Patienten

Publications (2)

Publication Number Publication Date
WO2008131746A2 WO2008131746A2 (de) 2008-11-06
WO2008131746A3 true WO2008131746A3 (de) 2009-02-19

Family

ID=39777541

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DE2008/000719 WO2008131746A2 (de) 2007-04-26 2008-04-28 Mittel zur präventiven antiinfektiven behandlung eines patienten

Country Status (2)

Country Link
DE (1) DE102007020152A1 (de)
WO (1) WO2008131746A2 (de)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1125579A2 (de) * 2000-01-18 2001-08-22 Pfizer Products Inc. Verwendungen von AGRP-Melanocortinrezeptorbindung modulierenden Verbindungen
WO2003074057A1 (de) * 2002-03-05 2003-09-12 Universitätsklinikum Charite Der Humboldt-Universität Zu Berlin Technologietransferstelle Antiinfektiva und/oder immunnodulatoren zur präventiven therapie nach akutem schlaganfall

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9827500D0 (en) * 1998-12-14 1999-02-10 Wapharm Ab Compounds for control of eating, growth and body weight
US20030032791A1 (en) * 2000-06-26 2003-02-13 Alan Robertson Scott Novel melanocortin-4 receptor sequences and screening assays to identify compounds useful in regulating animal appetite and metabolic rate
EP2236151B1 (de) * 2005-07-08 2012-05-23 Ipsen Pharma Melanocortinrezeptorliganden

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1125579A2 (de) * 2000-01-18 2001-08-22 Pfizer Products Inc. Verwendungen von AGRP-Melanocortinrezeptorbindung modulierenden Verbindungen
WO2003074057A1 (de) * 2002-03-05 2003-09-12 Universitätsklinikum Charite Der Humboldt-Universität Zu Berlin Technologietransferstelle Antiinfektiva und/oder immunnodulatoren zur präventiven therapie nach akutem schlaganfall

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
SCHULTE-HERBRUGGEN ET AL: "Alpha-MSH promotes spontaneous post-ischemic pneumonia in mice via melanocortin-receptor-1", EXPERIMENTAL NEUROLOGY, ACADEMIC PRESS, NEW YORK, NY, US, vol. 210, no. 2, 19 January 2008 (2008-01-19), pages 731 - 739, XP022577384, ISSN: 0014-4886 *

Also Published As

Publication number Publication date
DE102007020152A1 (de) 2008-10-30
WO2008131746A2 (de) 2008-11-06

Similar Documents

Publication Publication Date Title
UA108198C2 (uk) Заміщені 2-ацетамідо-5-арил-1,2,4-триазолони та їх застосування
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
IL210589A (en) C2386RV Protein Tuberculosis Kvfb Protein Use for the Treatment or Prevention of TB
EP2043679A4 (de) Zytotoxische t-lymphozyten-induzierende immunogene zur prävention, behandlung und diagnose von krebs
EP2061503A4 (de) Zytotoxische t-lymphozyten-induzierende immunogene zur prävention, behandlung und diagnose von krebs
IL207546A0 (en) Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases
EP1986639A4 (de) Pharmazeutische zusammensetzungen aus dextromethorphan und chinidin zur behandlung von depression, angstzuständen und neurodegenerativen erkrankungen
IL211842A (en) Antibodies or fragments of their human tgfbrii, pharmacological preparations containing them and their use in the preparation of a drug for inhibiting anogenesis
MX2009010407A (es) Derivados fluorados de deferiprona.
WO2010121164A3 (en) 1,4-benzodiazepinone compounds and their use in treating cancer
MX2009004561A (es) Derivados de pirazolilo con actividad analgesica y utiles en el tratamiento o profilaxis del dolor.
JO2645B1 (en) Vehicles
ZA201200944B (en) Pharmaceutical compositions for the treatment of cancer and other diseases or disorders
MX2009011999A (es) Extruidos con enmascaramiento del sabor mejorado.
IL177609A (en) Use of gobacoline or its analogue to produce a drug to treat liver carcinoma
PT2149372E (pt) Utilização de opióides do grupo da metadona para o tratamento de pacientes com cancros resistentes
CL2008000982A1 (es) Compuestos derivados de 5-oxo-isoxazol-carboxamida; proceso de preparacion; composicion farmaceutica; procedimiento de produccion de la composicion farmaceutica; y uso en el tratamiento y/o prevencion de trastornos ateroscleroticos, de metabolismo de
SG169346A1 (en) Use of yeast flakes for treating and/or preventing hyperinsulinemia
GB0715790D0 (en) Drug combination for the treatment of sialorrhoea
WO2011029639A3 (en) Compounds and methods for treating neoplasia
TW200731976A (en) Use of tiotropium salts in the treatment of moderate persistent asthma
UA96574C2 (ru) Использование ивабрадина для получения лекарств, предназначенных для лечения эндотелиальной дисфункции
WO2008131746A3 (de) Mittel zur präventiven antiinfektiven behandlung eines patienten
EP2517704A4 (de) Pharmazeutische zusammensetzungen zur behandlung von morbus parkinson und zubereitungsverfahren dafür
WO2008130321A3 (en) Novel n-tetrahydronaphtalene or 5-heterocyclyl-chromane or 8-heterocyclyl-tetrahydronaphtalene derivatives for the treatment of pain

Legal Events

Date Code Title Description
122 Ep: pct application non-entry in european phase

Ref document number: 08757980

Country of ref document: EP

Kind code of ref document: A2